Compare CNQ & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNQ | COR |
|---|---|---|
| Founded | 1973 | 2001 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Other Pharmaceuticals |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.0B | 57.4B |
| IPO Year | 1976 | N/A |
| Metric | CNQ | COR |
|---|---|---|
| Price | $32.80 | $341.23 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 13 |
| Target Price | $62.00 | ★ $354.85 |
| AVG Volume (30 Days) | ★ 6.8M | 1.5M |
| Earning Date | 11-06-2025 | 02-04-2026 |
| Dividend Yield | ★ 5.16% | 0.70% |
| EPS Growth | N/A | ★ 5.71 |
| EPS | 2.27 | ★ 7.96 |
| Revenue | $27,727,243,353.00 | ★ $321,332,819,000.00 |
| Revenue This Year | $9.74 | $7.20 |
| Revenue Next Year | N/A | $6.62 |
| P/E Ratio | ★ $14.37 | $42.85 |
| Revenue Growth | 8.06 | ★ 9.31 |
| 52 Week Low | $24.65 | $223.92 |
| 52 Week High | $35.12 | $377.54 |
| Indicator | CNQ | COR |
|---|---|---|
| Relative Strength Index (RSI) | 49.81 | 44.43 |
| Support Level | $31.25 | $336.41 |
| Resistance Level | $33.22 | $343.67 |
| Average True Range (ATR) | 0.68 | 5.45 |
| MACD | -0.07 | -0.69 |
| Stochastic Oscillator | 38.86 | 30.65 |
Canadian Natural Resources Ltd is an independent crude oil and natural gas exploration, development, and production company. The company's exploration and production operations are focused in North America, largely in Western Canada; the United Kingdom (UK) portion of the North Sea; and Cote d'Ivoire in Offshore Africa. Its operating segments include North America, North Sea, Offshore Africa, Oil Sands Mining and Upgrading, and Midstream and Refining. Maximum revenue is generated from its Oil Sands Mining and Upgrading segment, which produces synthetic crude oil through bitumen mining and upgrading operations at Horizon Oil Sands (Horizon) and the company's direct and indirect interest in the Athabasca Oil Sands Project.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.